Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The present study was designed to evaluate the combined efficacy of PRF and 1% ALN in the treatment of mandibular degree II furcation defects when compared with PRF and open flap debridement (OFD) alone.
Background: Various regenerative materials have been introduced and tested in the treatment of furcation defects. Platelet-rich fibrin (PRF) is a reservoir of growth factors and cytokines which are the key factors for regeneration of bone and maturation of the soft tissue. Alendronate (ALN), a potent member of bisphosphonate group is known to promote tissue regeneration by inhibiting osteoclastic bone resorption and promoting osteoblastogenesis. The present study was designed to evaluate the combined efficacy of PRF and 1% ALN in the treatment of mandibular degree II furcation defects when compared with PRF and open flap debridement (OFD) alone.
Methods: Seventy two mandibular furcation defects were treated with either OFD alone (Group 1), OFD with PRF (Group 2), and OFD with PRF+1% ALN (Group 3). Clinical parameters; site specific plaque index (PI), modified sulcus bleeding index (mSBI), probing depth (PD), relative vertical attachment level (RVAL) and relative horizontal attachment level (RHAL), intrabony defect depth (IBD) were recorded at baseline before surgery and 9 months post-operatively. Percentage radiographic defect fill was evaluated at baseline and 9 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1 | Active Comparator | Scaling and Root Planing (SRP) with Open flap debridement (OFD) alone for treating furcation defect |
|
| Group 2 | Active Comparator | SRP with Open flap debridement (OFD) with Platelet rich fibrin (PRF) for treating furcation defect |
|
| Group 3 | Active Comparator | SRP with Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1% Alendronate for treating furcation defect |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Open flap debridement (OFD) | Procedure | Open flap debridement (OFD) alone |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Radiographic bone fill | assessed in percentage | baseline to 9 months |
| Measure | Description | Time Frame |
|---|---|---|
| probing depth | measured in mm | baseline to 9 months |
| Relative vertical attachment level | measured in mm | baseline to 9 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Government Dental College and Research Institute | Bangalore | Karnataka | 560002 | India |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27712462 | Derived | Kanoriya D, Pradeep AR, Garg V, Singhal S. Mandibular Degree II Furcation Defects Treatment With Platelet-Rich Fibrin and 1% Alendronate Gel Combination: A Randomized Controlled Clinical Trial. J Periodontol. 2017 Mar;88(3):250-258. doi: 10.1902/jop.2016.160269. Epub 2016 Oct 7. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| OFD with Platelet rich fibrin (PRF) |
| Procedure |
Open flap debridement (OFD) with Platelet rich fibrin (PRF) placement |
|
| OFD with Platelet rich fibrin (PRF)+1% Alendronate (Drug) in gel form | Procedure | Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1% Alendronate gel placement |
|
| Relative horizontal attachment level | measured in mm | baseline to 9 months |
| modified sulcus bleeding index | 0-3 scale | baseline to 9 months |
| plaque index | 0-3 scale | baseline to 9 months |
| ID | Term |
|---|---|
| D017823 | Furcation Defects |
| ID | Term |
|---|---|
| D010510 | Periodontal Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided
Not provided